Founder Securities: A clear turning point in operations as they rebound from the bottom; leading food and beverage companies enter a new normal of moderate growth.

Under stricter regulations in the health supplements industry, mid- to low-tier brands may face accelerated elimination, while the market is expected to further consolidate around leading brands.

Zhitong FinanceMay 8 09:58

Lily Co., Ltd. (603102) 2025 Annual Report and 2026 Q1 Commentary: Brand Development and Cross-Border Expansion

Key investment highlights: Baihe released its 2025 annual report and Q1 2026 quarterly report. In 2025, revenue/net profit attributable to shareholders reached 911 million/128 million yuan, representing year-on-year changes of +13.67%/-7.81%, respectively. Revenue/net profit attributable to shareholders for Q4 2025 was

Dongwu SecuritiesApr 17 13:57

Baihe Co., Ltd. reported revenue of 9.11 billion yuan in 2025, marking a 13.67% increase, while its non-GAAP net profit reached 1.23 billion yuan, reflecting a 6.63% decline.

Both gross profit margin and net profit margin have slightly declined.

lanjinger.comApr 16 11:18

Baihe Co., Ltd.: First Quarter Report for 2026 of Weihai Baihe Biotechnology Co., Ltd.

SZSIApr 16 00:00 · Announcements

Baihe Co., Ltd.: Annual Report for 2025 of Weihai Baihe Biotechnology Co., Ltd.

SZSIApr 16 00:00 · Announcements

Baihe Co., Ltd.: Summary of the 2025 Annual Report of Weihai Baihe Biotechnology Co., Ltd.

SZSIApr 16 00:00 · Announcements